John B. Mumm
Directeur Général chez Deka Biosciences, Inc.
Profil
John B.
Mumm was the founder of ARMO BioSciences, Inc. (founded in 2010) and Deka Biosciences, Inc. (founded in 2019), where he holds the titles of Director-Non Clinical Research & Development and President & Chief Executive Officer respectively.
He also held former positions at Merck & Co., Inc. as a Senior Scientist, Anergen, Inc. as a Research Technician, Introgen Therapeutics, Inc. as a Consulting Scientist, and Bacterial Barcodes, Inc. as a Consulting Scientist.
Dr. Mumm obtained a graduate degree from Stanford University.
Postes actifs de John B. Mumm
| Sociétés | Poste | Début |
|---|---|---|
Deka Biosciences, Inc.
 Deka Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Deka Biosciences, Inc. is a biotech company based in Germantown, MD. Deka Biosciences is committed to developing and delivering life-changing medicines to patients with cancer and inflammatory diseases. The company has developed disease-specific diakines™ that are designed to maximize patient benefits through improved pharmacokinetics/pharmacodynamics function by the targeted accumulation of dual and complimentary cytokines into affected tissues. Deka Biosciences aims to build specific targeted therapies for everyone by developing a better understanding of each patient's immune response to different diakines™. The company was founded in 2019 by John B. Mumm and Pavel Khrimian, with John B. Mumm serving as the CEO since then. | Directeur Général | 01/01/2019 |
Anciens postes connus de John B. Mumm
| Sociétés | Poste | Fin |
|---|---|---|
| MERCK & CO., INC. | Corporate Officer/Principal | - |
Bacterial Barcodes, Inc.
 Bacterial Barcodes, Inc. Medical SpecialtiesHealth Technology Bacterial Barcodes, Inc. provides equipment, reagents, and software for microbial genotyping of bacteria and fungi. The company was founded on November 10, 2005 and is headquartered in Durham, NC. | Corporate Officer/Principal | - |
| Anergen, Inc. | Corporate Officer/Principal | - |
| INTROGEN THERPUT | Corporate Officer/Principal | - |
| ARMO BIOSCIENCES INC | Fondateur | - |
Formation de John B. Mumm
| Stanford University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
| Anergen, Inc. | Health Technology |
Introgen Therapeutics, Inc.
 Introgen Therapeutics, Inc. Medical SpecialtiesHealth Technology Introgen Therapeutics, Inc. is a biopharmaceutical company focuses on the discovery, development and commercialization of targeted molecular therapies for the treatment of cancer and other diseases. The company develops molecular therapeutics, immunotherapies, vaccines and nano-particle tumor suppressor therapies to treat a wide range of cancers using tumor suppressors, cytokines and genes. The company maintains integrated research, development, manufacturing, clinical and regulatory departments and operates multiple manufacturing facilities including a commercial scale cGMP manufacturing facility. It was founded in June 1993 and is headquartered in Austin, TX. | Health Technology |
Bacterial Barcodes, Inc.
Bacterial Barcodes, Inc. Medical SpecialtiesHealth Technology Bacterial Barcodes, Inc. provides equipment, reagents, and software for microbial genotyping of bacteria and fungi. The company was founded on November 10, 2005 and is headquartered in Durham, NC. | Health Technology |
ARMO BioSciences, Inc.
 ARMO BioSciences, Inc. Pharmaceuticals: MajorHealth Technology ARMO BioSciences, Inc. develops immunotherapy for the treatment of cancer, cardiovascular diseases, fibrosis, and inflammation. Its lead product candidate is AM0010 (pegilodecaki). The company was founded by Peter Van Vlasselaer, Martin Oft, and John B. Mumm on June 23, 2010 and is headquartered in Redwood, CA. | Health Technology |
Deka Biosciences, Inc.
Deka Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Deka Biosciences, Inc. is a biotech company based in Germantown, MD. Deka Biosciences is committed to developing and delivering life-changing medicines to patients with cancer and inflammatory diseases. The company has developed disease-specific diakines™ that are designed to maximize patient benefits through improved pharmacokinetics/pharmacodynamics function by the targeted accumulation of dual and complimentary cytokines into affected tissues. Deka Biosciences aims to build specific targeted therapies for everyone by developing a better understanding of each patient's immune response to different diakines™. The company was founded in 2019 by John B. Mumm and Pavel Khrimian, with John B. Mumm serving as the CEO since then. | Health Technology |
